Diabetic Kidney Disease: Symptoms, Tests, Stages, Treatment, and Prevention

Diabetes-related kidney disease is also called diabetic kidney disease, diabetic nephropathy, or diabetes-associated chronic kidney disease. It develops when diabetes and related conditions damage the kidneys’ filtering system over time.

The condition is important because kidney disease increases the risks of cardiovascular disease, medication-related hypoglycemia, anemia, fluid overload, and kidney failure. However, progression is not inevitable. Earlier diagnosis and treatment can preserve kidney function for many years.

What Is Diabetic Kidney Disease?

The kidneys contain approximately one million filtering units called nephrons. Inside each nephron, a cluster of tiny blood vessels called the glomerulus filters water and waste products while normally retaining most blood cells and proteins.

Diabetic kidney disease is diagnosed when abnormalities of kidney structure or function persist for at least three months and are attributed to diabetes. The most common findings are:

• Albumin leaking into the urine
• A reduced eGFR
• Both albuminuria and reduced filtration

Kidney disease can be present even when the eGFR is above 60 if albuminuria or another marker of kidney damage is persistent. Conversely, some people with diabetes develop a reduced eGFR without substantial albuminuria.

How Does Diabetes Damage the Kidneys?

The process is more complex than simple “thickening” of the glomerulus. Important mechanisms include:

• Glomerular hyperfiltration: early diabetes can increase pressure and blood flow inside the glomerulus.
• Damage to the filtration barrier: injury to endothelial cells, the basement membrane, and podocytes allows albumin to leak into the urine.
• Activation of hormonal pathways: the renin-angiotensin-aldosterone system can increase pressure within the glomerulus.
• Inflammation and fibrosis: persistent metabolic and hemodynamic stress can lead to scarring in glomeruli and the tubulointerstitial tissue.
• Blood-vessel disease: hypertension, smoking, and atherosclerosis can further reduce kidney health.

High glucose contributes to kidney damage, but glucose is not the only factor. Blood pressure, genetics, duration of diabetes, cardiovascular disease, smoking, obesity, kidney-toxic medicines, recurrent acute kidney injury, and social barriers to care also influence risk.

Who Is at Higher Risk?

• Longer duration of type 1 or type 2 diabetes
• Persistent glucose levels above the individualized target
• High blood pressure
• Albuminuria
• Cardiovascular disease or heart failure
• Smoking
• Obesity
• Family history of kidney failure
• Previous acute kidney injury
• Older age
• Diabetic retinopathy or neuropathy
• Use of medicines that can injure the kidneys

The old claim that nephropathy develops approximately 15 years after every diabetes diagnosis was inaccurate. It can appear at different times. Kidney disease may already be present when type 2 diabetes is first diagnosed, while screening for type 1 diabetes generally begins after five years unless there is another clinical reason to test earlier.

Symptoms of Diabetic Kidney Disease

Early diabetic kidney disease usually causes no symptoms. A person may feel well while urine albumin rises or eGFR falls. Waiting for swelling, nausea, or fatigue can delay diagnosis.

Possible symptoms in more advanced disease include:

• Swelling in the feet, ankles, legs, hands, or around the eyes
• Foamy urine caused by substantial protein loss
• Fatigue, weakness, reduced exercise tolerance, or shortness of breath from anemia
• Reduced appetite, nausea, vomiting, metallic taste, or unintentional weight loss
• Itching
• Muscle cramps
• Sleep problems
• Changes in urination
• Difficulty controlling blood pressure
• Confusion or drowsiness in severe kidney failure

These symptoms are not specific to kidney disease. Swelling may also be caused by heart failure, liver disease, venous problems, medication effects, or a blood clot. New swelling therefore needs medical assessment rather than self-treatment.

The Two Essential Kidney Tests

1. Urine albumin-to-creatinine ratio

The UACR measures the amount of albumin in a spot urine sample relative to creatinine. It is more useful than relying only on a urine dipstick because it corrects partly for urine concentration.

A single abnormal UACR does not always prove chronic kidney disease. Exercise, fever, urinary infection, menstruation, marked hyperglycemia, severe hypertension, and acute illness can temporarily increase albumin. The test is commonly repeated to confirm persistence.

2. Estimated glomerular filtration rate

The eGFR is calculated from a blood creatinine measurement and patient factors. It estimates how well the kidneys filter blood. A serum creatinine result alone can be misleading because age, muscle mass, diet, amputation, and other factors affect creatinine.

In some patients, clinicians may add cystatin C to improve eGFR accuracy—particularly when creatinine may not reflect muscle mass reliably or when a more accurate estimate would change treatment.

How often should testing be done?

• Type 2 diabetes: assess UACR and eGFR at least annually, beginning at diagnosis.
• Type 1 diabetes: assess at least annually after five years of diabetes, or earlier when clinically indicated.
• Established chronic kidney disease: monitor from one to four or more times per year depending on eGFR, albuminuria, rate of change, medicines, and clinical risk.

Understanding eGFR Stages

The stage is not interpreted from eGFR alone. Risk is determined by the combination of eGFR, UACR, cause of kidney disease, rate of decline, cardiovascular disease, and other clinical factors.

Does Albumin in the Urine Always Mean Diabetic Kidney Disease?

No. Diabetes is a common cause, but urinary albumin can result from other kidney diseases, severe hypertension, infection, heart failure, exercise, fever, or temporary illness.

Features that may suggest a non-diabetic or additional kidney disease include:

• Blood or active sediment in the urine
• Rapidly rising albuminuria
• Sudden nephrotic syndrome
• Rapid eGFR decline
• Very short diabetes duration
• Systemic symptoms suggesting autoimmune or inflammatory disease
• Kidney findings that do not fit the overall diabetes history

Is a kidney biopsy routinely required?

No. A kidney biopsy is not routinely used to confirm typical diabetic kidney disease. It may be considered when the diagnosis is uncertain or another kidney disorder is suspected. The decision belongs to a nephrologist after reviewing blood tests, urine findings, imaging, diabetes duration, retinopathy, and the rate of change.

Treatment of Diabetic Kidney Disease

Modern treatment is not limited to “strict glucose control” or vasodilators. It combines several kidney- and cardiovascular-protective strategies.

1. Individualized glucose management

Improving glucose control helps prevent or slow diabetic kidney disease, but the safest goal depends on age, diabetes duration, CKD stage, cardiovascular disease, treatment burden, and hypoglycemia risk.

An HbA1c target below 7% is common for many nonpregnant adults when it can be achieved safely, but some people need a less stringent target. As kidney function falls, insulin and certain medicines may remain in the body longer, increasing hypoglycemia risk. Medication doses and glucose targets may need adjustment.

Learn more from our diabetes blood sugar guide and diabetes medication comparison.

2. Blood-pressure treatment

Blood-pressure control is one of the strongest ways to slow CKD progression and reduce cardiovascular events. ADA 2026 recommends a general target below 130/80 mmHg for people with diabetes and CKD when it can be reached safely. A lower systolic target may be considered for selected patients with high kidney or cardiovascular risk, but treatment must account for dizziness, falls, frailty, and medication side effects.

3. ACE inhibitors or ARBs

An ACE inhibitor or angiotensin receptor blocker is recommended for many nonpregnant people who have diabetes, hypertension, and albuminuria. These medicines lower systemic and intraglomerular pressure and can reduce albuminuria and CKD progression.

Examples of ACE inhibitors include lisinopril, ramipril, and enalapril. Examples of ARBs include losartan, valsartan, and irbesartan. “Sartans” are ARBs—not ACE inhibitors.

Important safety points:

• Do not combine an ACE inhibitor with an ARB.
• Check creatinine and potassium after starting or increasing the dose.
• A mild creatinine rise can occur and does not automatically require stopping treatment.
• These medicines are generally avoided during pregnancy.
• Persistent cough can occur with ACE inhibitors; angioedema is rare but urgent.

4. SGLT2 inhibitors

For many adults with type 2 diabetes and CKD, an SGLT2 inhibitor with proven benefit is recommended to reduce kidney-disease progression and cardiovascular events when eGFR is at least 20 mL/min/1.73 m².

Examples include empagliflozin, dapagliflozin, and canagliflozin. Their kidney and heart benefits are not explained only by glucose lowering.

Possible risks include genital yeast infection, dehydration, low blood pressure, and rare ketoacidosis that may occur without extremely high glucose. Patients need sick-day and perioperative instructions. These medicines are not used as a substitute for insulin in type 1 diabetes.

5. Finerenone

Finerenone is a nonsteroidal mineralocorticoid receptor antagonist. In adults with type 2 diabetes and CKD, it can reduce the risks of sustained eGFR decline, kidney failure, and cardiovascular events when used in appropriate patients.

It is generally considered for persistent albuminuria despite standard care, with adequate eGFR and acceptable potassium. Potassium and eGFR must be checked before treatment and monitored afterward because hyperkalemia can occur.

6. GLP-1 receptor agonists

GLP-1 receptor agonists can improve glucose control, support weight loss, and reduce cardiovascular risk with selected agents. They are useful when individualized glucose goals are not met with metformin and an SGLT2 inhibitor, when those medicines cannot be used, or when cardiovascular and weight-related benefits are priorities.

Some GLP-1–based therapies also have evidence of kidney benefit, especially through reductions in albuminuria and cardiovascular events.

7. Lipids, smoking, and cardiovascular risk

Chronic kidney disease greatly increases cardiovascular risk. Statin therapy, smoking cessation, physical activity when safe, weight management, and treatment of heart failure or vascular disease may be as important as glucose lowering.

8. Nutrition for diabetic kidney disease

There is no single kidney diet for every patient. Needs change with eGFR, UACR, potassium, phosphorus, blood pressure, edema, dialysis status, appetite, and malnutrition risk.

General principles may include:

• Use a moderate protein intake rather than a high-protein diet when not on dialysis.
• Reduce excessive sodium, especially with hypertension or swelling.
• Choose minimally processed foods more often.
• Adjust potassium or phosphorus only when blood tests and the clinical situation require it.
• Avoid unregulated herbal “kidney cleanses.”
• Work with a renal dietitian when CKD is moderate, advanced, or nutritionally complex.

A blanket very-low-carbohydrate or high-protein diet may be unsafe in some people with CKD. Meal planning should balance glucose management with kidney protection. See our diabetes foods guide.

9. Avoid preventable kidney injury

Ask before using nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, or diclofenac—especially during dehydration or while taking a diuretic, ACE inhibitor, or ARB. Review contrast imaging, supplements, proton-pump inhibitors, antibiotics, and over-the-counter products with the healthcare team.

Do not stop an indicated medicine merely because it is cleared by the kidneys. Many medicines can be used safely with the correct dose and monitoring.

Anemia and Other CKD Complications

The kidneys produce erythropoietin, a hormone that helps the bone marrow make red blood cells. As CKD advances, reduced erythropoietin can contribute to anemia. However, iron deficiency, blood loss, inflammation, vitamin B12 deficiency, and other causes must also be assessed.

Advanced CKD may also cause:

• High potassium
• Metabolic acidosis
• Mineral and bone disorder
• Fluid overload
• Malnutrition
• Medication accumulation
• Higher hypoglycemia risk

These complications require laboratory monitoring and individualized treatment. Erythropoiesis-stimulating therapy is not started simply because a patient feels tired.

When Should a Nephrologist Be Involved?

Referral or co-management may be appropriate when there is:

• Continuously rising UACR
• Continuously falling eGFR
• eGFR below 30 mL/min/1.73 m²
• Uncertain cause of kidney disease
• Rapid progression
• Resistant hypertension
• Persistent high potassium
• Severe albuminuria or nephrotic syndrome
• Anemia, acidosis, or mineral-bone complications that are difficult to manage
• Need for kidney-failure education, dialysis planning, or transplant evaluation

Does Diabetic Kidney Disease Always Lead to Dialysis?

No. Most people with diabetes and kidney disease do not progress to kidney failure. Modern treatment can slow or sometimes stabilize the decline.

Dialysis or transplantation is considered when kidney function becomes severely reduced and symptoms, fluid overload, potassium, acidosis, nutrition, or other complications can no longer be managed safely. Decisions are not based on one creatinine or eGFR result alone.

Dialysis is not merely a temporary bridge for every patient. Some people remain on dialysis long term, some receive a kidney transplant, and some choose conservative kidney management based on health status and personal goals.

Does Having One Kidney Cause a False Diabetes Reading?

Having one functioning kidney does not by itself create a false fasting glucose, random glucose, or home glucose-meter result. Diabetes is still diagnosed using standard laboratory criteria.

However, advanced kidney disease can affect the interpretation of HbA1c. Anemia, shortened red-cell lifespan, erythropoietin treatment, blood transfusion, iron therapy, and hemodialysis can make HbA1c less reliable. When HbA1c does not match finger-stick or CGM readings, the clinician may use glucose data, fructosamine, glycated albumin, or another approach.

A solitary kidney also does not automatically mean kidney failure. Many people live normally with one healthy kidney, but they should monitor blood pressure, eGFR, urine albumin, and avoid preventable kidney injury.

Doctor’s Note

Most Asked Questions

Can diabetic kidney disease be reversed?

Established scarring may not fully reverse, but albuminuria can decrease and progression can slow substantially. Early treatment offers the best opportunity to preserve kidney function.

What is the earliest sign?

Persistent albumin in the urine is a common early finding, but some patients first show a falling eGFR. This is why both tests are required.

Can I have kidney disease with normal creatinine?

Yes. Serum creatinine can remain within the laboratory reference range despite early kidney damage. eGFR and UACR provide more useful information.

Should everyone with diabetes take an ACE inhibitor?

No. ACE inhibitors and ARBs are particularly important for people with hypertension and albuminuria or reduced eGFR, but treatment depends on blood pressure, pregnancy, potassium, kidney function, and tolerance.

Do SGLT2 inhibitors protect the kidneys even if glucose is controlled?

In appropriate adults with type 2 diabetes and CKD, kidney and cardiovascular benefits can occur independently of a large glucose-lowering effect.

Does foamy urine mean kidney disease?

Persistent foam may suggest protein in the urine, but dehydration, urine speed, and cleaning products can also cause bubbles. A UACR test is needed.

Can herbs improve kidney blood flow?

No herbal product should be used as a substitute for ACE inhibitors, ARBs, SGLT2 inhibitors, finerenone, or other prescribed treatment. Some herbs can worsen kidney function or alter potassium.

Related Questions

• What Is the Link Between Lisinopril, Diabetes, and Kidney Protection?
• Will Lowering Blood Sugar Reduce Swelling?
• Why Can HbA1c and Finger-Prick Results Disagree?

Related Resources

• Diabetes Complications and Prevention
• Diabetes Medicines: Benefits and Side Effects
• Type 2 Diabetes Information
• Diabetes Blood Sugar Levels
• HbA1c Explained
• Diabetes Foods and Meal Planning

References

1. American Diabetes Association. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026.
2. KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease—2024.
3. NIDDK. Diabetic Kidney Disease.
4. NIDDK. Quick Reference on UACR and GFR.
5. U.S. FDA. Finerenone Prescribing Information.
6. NIDDK. The A1C Test and Conditions That Affect Accuracy.